Selway Asset Management Abb Vie Inc. Transaction History

Selway Asset Management

$254 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $521,001 - $603,135	-3,900 Reduced 26.94%	10,575 $1.58 Million
Q2 2023 Jul 27, 2023	SELL	$132.51 - $164.9 $363,739 - $452,650	-2,745 Reduced 15.94%	14,475 $1.95 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $3.24 Million - $3.73 Million	-22,417 Reduced 56.56%	17,220 $2.74 Million
Q4 2022 Feb 17, 2023	BUY	$138.31 - $165.87 $69,155 - $82,935	500 Added 1.28%	39,637 $6.41 Million
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $162,796 - $186,717	-1,213 Reduced 3.01%	39,137 $5.25 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $5.54 Million - $7.04 Million	-40,250 Closed	0 $0
Q1 2022 Apr 11, 2022	BUY	$131.98 - $163.75 $229,645 - $284,925	1,740 Added 4.52%	40,250 $6.53 Million
Q4 2021 Jan 19, 2022	SELL	$107.43 - $135.93 $26,857 - $33,982	-250 Reduced 0.64%	38,510 $5.21 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $10,640 - $12,078	100 Added 0.26%	38,760 $4.18 Million
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $36,823 - $41,023	350 Added 0.91%	38,660 $4.36 Million
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $104,346 - $114,872	1,020 Added 2.74%	38,310 $4.15 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $325,984 - $440,113	4,050 Added 12.18%	37,290 $4 Million
Q3 2020 Oct 28, 2020	SELL	$85.91 - $100.83 $4,295 - $5,041	-50 Reduced 0.15%	33,240 $2.91 Million
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $12,839 - $17,181	175 Added 0.53%	33,290 $3.27 Million
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $203,820 - $309,016	-3,160 Reduced 8.71%	33,115 $2.52 Million
Q4 2019 Jan 23, 2020	SELL	$72.13 - $90.25 $44,720 - $55,955	-620 Reduced 1.68%	36,275 $3.21 Million
Q3 2019 Oct 24, 2019	BUY	$62.98 - $75.72 $157,135 - $188,921	2,495 Added 7.25%	36,895 $2.79 Million
Q2 2019 Jul 30, 2019	BUY	$65.7 - $83.98 $1.19 Million - $1.52 Million	18,150 Added 111.69%	34,400 $2.5 Million
Q1 2019 Apr 18, 2019	BUY	$77.14 - $90.79 $183,207 - $215,626	2,375 Added 17.12%	16,250 $1.31 Million
Q4 2018 Jan 30, 2019	SELL	$77.85 - $96.01 $23,355 - $28,803	-300 Reduced 2.12%	13,875 $1.28 Million
Q3 2018 Oct 30, 2018	SELL	$88.91 - $98.84 $382,313 - $425,012	-4,300 Reduced 23.27%	14,175 $1.34 Million
Q2 2018 Jul 24, 2018	SELL	$89.78 - $106.23 $143,648 - $169,968	-1,600 Reduced 7.97%	18,475 $1.71 Million
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $174,819 - $234,099	-1,900 Reduced 8.65%	20,075 $1.9 Million
Q4 2017 Jan 31, 2018	SELL	$89.56 - $98.21 $474,668 - $520,512	-5,300 Reduced 19.43%	21,975 $2.13 Million
Q3 2017 Oct 24, 2017	BUY	$69.85 - $89.22 $1.91 Million - $2.43 Million	27,275	27,275 $2.42 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Selway Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Selway Asset Management with notifications on news.

Account